Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mathias C. Busch is active.

Publication


Featured researches published by Mathias C. Busch.


Annals of Emergency Medicine | 2011

Asymptomatic Sustained Ventricular Fibrillation in a Patient With Left Ventricular Assist Device

Mathias C. Busch; Michael Haap; Arnt V. Kristen; Christian S. Haas

Optimal medical treatment, cardiac resynchronization, and the use of an implantable cardioverter defibrillator are established therapies of severe congestive heart failure. In refractory cases, left ventricular assist devices are more and more used not only as bridging to cardiac transplantation but also as destination therapy. Ventricular arrhythmias may represent a life-threatening condition and often result in clinical deterioration in patients with congestive heart failure. We report a case of asymptomatic sustained ventricular fibrillation with preserved hemodynamics caused by a nonpulsatile left ventricular assist device. Consecutive adequate but unsuccessful discharges of the implantable cardioverter defibrillator were the only sign of the usually fatal arrhythmia, prompting the patient to consult emergency services. Electrolyte supplementation and initiation of therapy with amiodarone followed by external defibrillation resulted in successful restoration of a stable cardiac rhythm after 3.5 hours.


Acta Biomaterialia | 2014

New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets.

Raila Busch; Anne Strohbach; Stefanie Rethfeldt; Simon Walz; Mathias C. Busch; Svea Petersen; Stephan B. Felix; Katrin Sternberg

Despite the development of new coronary stent technologies, in-stent restenosis and stent thrombosis are still clinically relevant. Interactions of blood and tissue cells with the implanted material may represent an important cause of these side effects. We hypothesize material-dependent interaction of blood and tissue cells. The aim of this study is accordingly to investigate the impact of vascular endothelial cells, smooth muscle cells and platelets with various biodegradable polymers to identify a stent coating or platform material that demonstrates excellent endothelial-cell-supportive and non-thrombogenic properties. Human umbilical venous endothelial cells, human coronary arterial endothelial cells and human coronary arterial smooth muscle cells were cultivated on the surfaces of two established biostable polymers used for drug-eluting stents, namely poly(ethylene-co-vinylacetate) (PEVA) and poly(butyl methacrylate) (PBMA). We compared these polymers to new biodegradable polyesters poly(l-lactide) (PLLA), poly(3-hydroxybutyrate) (P(3HB)), poly(4-hydroxybutyrate) (P(4HB)) and a polymeric blend of PLLA/P(4HB) in a ratio of 78/22% (w/w). Biocompatibility tests were performed under static and dynamic conditions. Measurement of cell proliferation, viability, glycocalix width, eNOS and PECAM-1 mRNA expression revealed strong material dependency among the six polymer samples investigated. Only the polymeric blend of PLLA/P(4HB) achieved excellent endothelial markers of biocompatibility. Data show that PLLA and P(4HB) tend to a more thrombotic response, whereas the polymer blend is characterized by a lower thrombotic potential. These data demonstrate material-dependent endothelialization, smooth muscle cell growth and thrombogenicity. Although polymers such as PEVA and PBMA are already commonly used for vascular implants, they did not sufficiently meet the criteria for biocompatibility. The investigated biodegradable polymeric blend PLLA/P(4HB) evidently represents a promising material for vascular stents and stent coatings.


Cellular Signalling | 2015

Regulation of the endothelial apelin/APJ system by hemodynamic fluid flow.

Raila Busch; Anne Strohbach; Malte Pennewitz; Florian Lorenz; Martin Bahls; Mathias C. Busch; Stephan B. Felix

Although the apelin/APJ system is abundantly expressed in vascular endothelial cells (EC), it has not yet been considered to be regulated by fluid flow. The aim of this study was to explore the influence of shear stress on the expression of apelin/APJ in human EC. Therefore, gene and protein expression were assessed after flow exposure; cell supernatants were collected for measurements of NO and apelin; APJ or apelin knockdown were performed using siRNA. Our data show that gene and protein expression of apelin and APJ are modulated by fluid flow depending on the magnitude of shear stress. Moreover, apelin-12 activated NO production via PI3K/Akt signaling in human EC. In contrast, apelin-13 additionally activated Erk1/2 phosphorylation and enhanced EC proliferation. Knockdown of APJ inhibited phosphorylation of PI3K and impaired flow-induced eNOS and PECAM-1 expression. Knockdown of apelin had no influence on flow-induced APJ and PECAM-1 expression, but derogated eNOS expression under static and flow conditions. The present study reveals a flow-mediated adjustment of the apelin/APJ system in human EC in which APJ expression is induced by shear stress independently of its ligand. Furthermore, apelin-12 signaling is an essential regulatory element in endothelial NO synthesis.


American Journal of Cardiology | 2015

Multicenter Long-Term Validation of a Minicourse in Radiation-Reducing Techniques in the Catheterization Laboratory

Eberhard Kuon; Kerstin Weitmann; Wolfgang Hoffmann; Marcus Dörr; Astrid Hummel; Alexander Riad; Mathias C. Busch; Stephan B. Felix; Klaus Empen

Patient radiation exposure in invasive cardiology is considerable. We aimed to investigate, in a multicenter field study, the long-term efficacy of an educational 90-minute workshop in cardiac invasive techniques with reduced irradiation. Before and at a median period of 2.5 months and 2.0 years after the minicourse (periods I, II, and III, respectively) at 5 German cardiac centers, 18 interventionalists documented various radiation parameters for 10 coronary angiographies. The median patient dose area product (DAP) for periods I, II, and III amounted to 26.6, 12.2, and 9.6 Gy × cm(2), respectively. The short-term and long-term effects were related to shorter median fluoroscopy times (180, 138, and 114 seconds), fewer radiographic frames (745, 553, and 417) because of fewer (11, 11, and 10) and shorter (64, 52, and 44 frames/run) runs, consistent collimation, and restriction to an adequate image quality; both radiographic DAP/frame (27.7, 17.3, and 18.4 mGy × cm(2)) and fluoroscopic DAP/second (26.6, 12.9, and 14.9 mGy × cm(2)) decreased significantly. Multivariate analysis over time indicated increasing efficacy of the minicourse itself (-55% and -64%) and minor influence of interventionist experience (-4% and -3% per 1,000 coronary angiographies, performed lifelong until the minicourse and until period III). In conclusion, autonomous self-surveillance of various dose parameters and feedback on individual radiation safety efforts supported the efficacy of a 90-minute course program toward long-lasting and ongoing patient dose reduction.


BMC Clinical Pharmacology | 2015

Riociguat and cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats

Yvonne Reinke; Stefan Gross; Lars G. Eckerle; Isabel Hertrich; Mathias C. Busch; Raila Busch; Alexander Riad; Bernhard Rauch; Johannes-Peter Stasch; Marcus Dörr; Stephan B. Felix

Clinical background In the clinical setting, administration of organic nitrates and nitric oxide (NO) donors has serious limitations such as resistance to NO and organic nitrates due to insufficient biometabolism and development of tolerance following prolonged administration of NO soluble guanylate cyclase (sGC) to NO [1,2]. This circumstance has led to development of heme-dependent sGC stimulators and heme-independent sGC activators. The sGC stimulator riociguat and the sGC activator cinaciguat have been shown to induce various beneficial effects in both experimental and clinical research. Any direct dosedependent effects of these compounds on cell contraction and relaxation of isolated cardiac myocytes, however, remain to be elucidated [3].


Journal of Cellular Physiology | 2018

The apelin receptor influences biomechanical and morphological properties of endothelial cells

Anne Strohbach; Malte Pennewitz; Michael Glaubitz; Raghavendra Palankar; Stefan Groß; Florian Lorenz; Ilka Materzok; Alena Rong; Mathias C. Busch; Stephan B. Felix; Mihaela Delcea; Raila Busch

The adaption of endothelial cells to local flow conditions is a multifunctional process which leads to distinct alterations in cell shape, the subcellular distribution of structural proteins, and cellular function. G‐protein‐coupled receptors (GPCRs) have been identified to be fundamentally involved in such processes. Recently, we and others have shown that the expression of the endothelial GPCR apelin receptor (APJ) is regulated by fluid flow and that activation of APJ participates in signaling pathways which are related to processes of mechanotransduction. The present study aims to illuminate these findings by further visualization of APJ function. We show that APJ is located to the cellular junctions and might thus be associated with platelet endothelial cell adhesion molecule‐1 (PECAM‐1) in human umbilical vein endothelial cells (HUVEC). Furthermore, siRNA‐mediated silencing of APJ expression influences the shear‐induced adaption of HUVEC in terms of cytoskeletal remodeling, cellular elasticity, cellular motility, attachment, and distribution of adhesion complexes. Taken together, our results demonstrate that APJ is crucial for complemented endothelial adaption to local flow conditions.


Annals of Noninvasive Electrocardiology | 2017

Impact of atrial fibrillation detected by extended monitoring—A population‐based cohort study

Mathias C. Busch; Stefan Gross; Dietrich Alte; Jan A. Kors; Henry Völzke; Till Ittermann; André Werner; Anne Krüger; Raila Busch; Marcus Dörr; Stephan B. Felix

The clinical relevance of extended monitoring of AF in the general population is unclear. The study evaluated the detection of AF using transtelephonic electrocardiography and the clinical relevance of additional AF findings, especially with regard to stroke risk and mortality.


Jacc-cardiovascular Interventions | 2013

Transesophageal echocardiography-guided, bed-side bail-out aortic valvuloplasty.

Mathias C. Busch; Sigrun Friesecke; Klaus Empen; Stephan B. Felix

A 73-year-old man developed hemodynamic deterioration in the context of bilateral pneumonia, despite treatment of septic shock according to guidelines. Transthoracic echocardiography was of poor quality, due to obesity, but revealed severely reduced left ventricular (LV) function. Significant


Jacc-cardiovascular Interventions | 2014

Efficacy of a minicourse in radiation-reducing techniques in invasive cardiology: a multicenter field study.

Eberhard Kuon; Kerstin Weitmann; Wolfgang Hoffmann; Marcus Dörr; Thorsten Reffelmann; Astrid Hummel; Alexander Riad; Mathias C. Busch; Klaus Empen; Stephan B. Felix


Herz | 2015

Latest-generation catheterization systems enable invasive submillisievert coronary angiography

Eberhard Kuon; Kerstin Weitmann; A. Hummel; Marcus Dörr; T. Reffelmann; A. Riad; Mathias C. Busch; Stephan B. Felix; Wolfgang Hoffmann; Klaus Empen

Collaboration


Dive into the Mathias C. Busch's collaboration.

Top Co-Authors

Avatar

Marcus Dörr

University of Greifswald

View shared research outputs
Top Co-Authors

Avatar

Klaus Empen

University of Greifswald

View shared research outputs
Top Co-Authors

Avatar

Raila Busch

University of Greifswald

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Riad

University of Greifswald

View shared research outputs
Top Co-Authors

Avatar

Anne Strohbach

University of Greifswald

View shared research outputs
Top Co-Authors

Avatar

Stefan Gross

University of Greifswald

View shared research outputs
Researchain Logo
Decentralizing Knowledge